Jang HM, Bae S, Jung J, Cho H, Yoon DH, Kim SH. Immunity Against Measles in Korean Autologous Hematopoietic Stem Cell Transplant Recipients.
J Korean Med Sci 2024;
39:e224. [PMID:
39048304 PMCID:
PMC11263764 DOI:
10.3346/jkms.2024.39.e224]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/14/2024] [Accepted: 06/16/2024] [Indexed: 07/27/2024] Open
Abstract
The seropositivity of measles antibodies among 261 autologous stem cell transplant recipients (ASCTs) in Korea, assessed approximately 1-2 years after transplant (median, 11 months; interquartile range, 9-14), was significantly lower than age- and sex-matched control healthcare workers (83.1% [217/261] vs. 90.3% [539/597], P = 0.002). The findings underscore the vulnerability of adult ASCT recipients to measles. Clinicians should prioritize testing for measles IgG after ASCT and consider vaccination for ASCT recipients who remain seronegative 2 years after ASCT.
Collapse